SEO URLwww.firestrike.ai/deals/newcells-biotech-ophthalmology-unit-axol-bioscience-acquisition-2026
acquisitionAnnounced · Feb 18, 2026BiotechnologySource · CredibleArticle · Factual
Axol Bioscience acquires Newcells Biotech ophthalmology unit
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$2.8M
Target
Newcells Biotech ophthalmology unit
Acquirer
Axol Bioscience
Full Acquisition
Status
Announced
Axol Bioscience agreed to acquire Newcells Biotech ophthalmology unit. Reported deal value: $2.8M. Status: Announced. Sector: Biotechnology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-02-18. Figures and status may change as filings and press coverage update.
Axol Bioscience acquires Newcells Biotech ophthalmology unit
Deal timeline
Announced
Feb 18, 2026 · pharmatimes.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $2.8M. Figures and status may change as sources update.
Sources: pharmatimes.com · Primary article · FireStrike proprietary index